AnaptysBio, Inc. ANAB Unrealized gains (losses) on available-for-sale securities
Unrealized gains (losses) on available-for-sale securities at other companies
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s unrealized gains (losses) on available-for-sale securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s unrealized gains (losses) on available-for-sale securities?
- AnaptysBio, Inc. (ANAB) reported unrealized gains (losses) on available-for-sale securities of -$122K in Q1 2026.
- How has AnaptysBio, Inc.'s unrealized gains (losses) on available-for-sale securities changed year-over-year?
- AnaptysBio, Inc.'s unrealized gains (losses) on available-for-sale securities increased by 15.3% year-over-year, from -$144K to -$122K.
- What does unrealized gains (losses) on available-for-sale securities mean?
- This metric tracks the fluctuations in the fair value of investment securities held by the company that are classified as available-for-sale. It captures unrealized gains or losses that are excluded from net income but impact the total equity position. This provides insight into the volatility and performance of the company's treasury management and liquid asset portfolio.